Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People With Human Immunodeficiency Virus

J Infect Dis. 2021 Feb 13;223(3):403-408. doi: 10.1093/infdis/jiaa380.

Abstract

We performed a retrospective study of coronavirus disease 2019 (COVID-19) in people with human immunodeficiency virus (PWH). PWH with COVID-19 demonstrated severe lymphopenia and decreased CD4+ T cell counts. Levels of inflammatory markers, including C-reactive protein, fibrinogen, D-dimer, interleukin 6, interleukin 8, and tumor necrosis factor α were commonly elevated. In all, 19 of 72 hospitalized individuals (26.4%) died and 53 (73.6%) recovered. PWH who died had higher levels of inflammatory markers and more severe lymphopenia than those who recovered. These findings suggest that PWH remain at risk for severe manifestations of COVID-19 despite antiretroviral therapy and that those with increased markers of inflammation and immune dysregulation are at risk for worse outcomes.

Keywords: COVID-19; HIV; SARS-CoV-2; coronavirus; inflammation; people living with HIV.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • COVID-19 / blood
  • COVID-19 / immunology*
  • COVID-19 / mortality
  • COVID-19 / virology*
  • Female
  • HIV Infections / blood
  • HIV Infections / immunology*
  • HIV Infections / mortality
  • HIV Infections / virology*
  • HIV-1 / isolation & purification
  • Hospitalization / statistics & numerical data
  • Humans
  • Inflammation / blood
  • Inflammation / immunology
  • Inflammation / virology
  • Inflammation Mediators / blood
  • Inflammation Mediators / immunology
  • Lymphocyte Count
  • Lymphopenia / virology
  • Male
  • Middle Aged
  • New York / epidemiology
  • Retrospective Studies
  • Risk Factors
  • SARS-CoV-2 / isolation & purification

Substances

  • Inflammation Mediators